The $350m fund will provide capital for Gingko spinoffs and has attracted limited partners including Viking Global Investors, General Atlantic and Cascade Investment.

US-based microbe engineering firm Ginkgo Bioworks unveiled a $350m investment vehicle called Ferment Consortium yesterday that will finance startups spun off from the company. Ferment Consortium is funded by Gingko’s “major investors,” the company said, identifying hedge fund manager Viking Global Investors, growth equity firm General Atlantic and investment holding company Cascade Investment as backers.…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.